Christopher Sorensen, MD
Psychiatry · Draper, UTNPI 1912228230
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 74 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 14 manufacturers reported payments, led by Johnson & Johnson at 25.4% of the total. 2025 is the largest year on record at $541, 4.3 times the $125 reported in 2019.
Across 74 payments — averaging $21.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$409
- AbbVie$289
- Vanda Pharmaceuticals Inc.$182
- Neurocrine Biosciences, Inc.$166
- Teva Pharmaceuticals USA, Inc.$119
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$115
- plus $326 from 8 others
What the payments were for
- Food & beverage$1,606100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 8 | $409 |
| AbbVie | 21 | $289 |
| Vanda Pharmaceuticals Inc. | 7 | $182 |
| Neurocrine Biosciences, Inc. | 7 | $166 |
| Teva Pharmaceuticals USA, Inc. | 7 | $119 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 6 | $115 |
| Otsuka America Pharmaceutical, Inc. | 6 | $114 |
| Lundbeck LLC | 4 | $69 |
| Axsome Therapeutics, Inc. | 2 | $38 |
| Biogen | 2 | $34 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $23 |
| Ironshore Pharmaceuticals Inc. | 1 | $17 |
| Alkermes, Inc. | 1 | $16 |
| Corium, LLC | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SPRAVATO$269
How this compares
$1,606 in reported general payments places this provider in the 85th percentile of 231 psychiatry providers in Utah.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clozapine | 82 | $3,924 |
| Lurasidone Hcl | 19 | $1,145 |
| Gabapentin | 23 | $805 |
| Mirtazapine | 41 | $789 |
| Escitalopram Oxalate | 24 | $700 |
| Propranolol Hcl | 23 | $627 |
| Duloxetine Hcl | 34 | $619 |
| Lamotrigine | 24 | $440 |
| Trazodone Hcl | 38 | $413 |
| Bupropion XlBupropion Hcl | 21 | $395 |
| Bupropion Hcl SrBupropion Hcl | 22 | $395 |
| Clonazepam | 44 | $389 |
| Hydroxyzine Hcl | 14 | $389 |
| Temazepam | 20 | $329 |
| Fluoxetine Hcl | 18 | $222 |
Paid to pharmacies, not to this prescriber.
Other psychiatry in Draper
- Trent HolmbergDraper$32K
- Sheena RayDraper$402
- Sachin RajhansDraper$297
- Michael ConnollyDraper$256
- Michael MeasomSlc$2.2M
- Noel GardnerSalt Lake City$512K
- Reid RobisonOrem$133K
- Thomas RaynerProvo$60K
- Nathan CurrierRiverton$21K
- Oliver McPhersonBountiful$20K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.